Exhibiton Event
Jeisys Medical Hosts Global Symposium 'TEA Paris 2026' and Participates in 'IMCAS World Congress,' Solidifying European Market Presence
Proving Technological Superiority with Key Devices Certified as Leading World-Class Products
PARIS, France – Jeisys Medical Inc., a prominent global developer of medical aesthetic energy-based devices, successfully elevated its international brand authority by hosting its exclusive global symposium, 'TEA (Tailored Excellence in Aesthetics) Paris 2026,' and participating as a prominent exhibitor at the 'IMCAS World Congress 2026' held in Paris, France.
Through these major consecutive events, Jeisys Medical showcased the clinical efficacy and advanced technological capabilities of its flagship product lines—including POTENZA (Microneedle RF), DENSITY (Monopolar/Bipolar RF), and LinearZ (HIFU)—directly in the heart of the European market. The company also declared its strategic transition to accelerate manufacturer-driven global operations, focusing on maximizing customer satisfaction and physician trust worldwide.
On January 28, Jeisys Medical hosted its premier pre-congress event, 'TEA Paris 2026,' at The Peninsula Paris. The exclusive symposium attracted approximately 100 elite global distributors and Key Opinion Leaders (KOLs) from Europe, the Americas, and Asia. Under the central theme, "POTENZA Unveiled: Shaping the Next Era of RF Microneedling," the event successfully highlighted Jeisys Medical's technological innovation, fostering high-level networking and aligning international partners with the company's long-term global vision.
Following the symposium, Jeisys Medical participated in 'IMCAS Paris 2026' from January 29 to 31 as an official Gold Sponsor. The company operated the 'Experience Jeisys' showcase, featuring six of its premium medical platforms, including POTENZA, DENSITY Noir, and LinearZ. The booth garnered significant attention from international dermatologists and plastic surgeons through a series of clinical lectures delivered by global aesthetic experts, alongside interactive, hands-on training sessions.
"The Paris events served as a critical milestone to accelerate our manufacturer-driven global strategy, with POTENZA leading the expansion to deliver unprecedented value to the aesthetic market," said an official from Jeisys Medical. "Moving forward, Jeisys Medical remains committed to deepening our collaborative partnerships with global practitioners and continuously introducing data-driven, innovative medical platforms to elevate patient outcomes."
Through these major consecutive events, Jeisys Medical showcased the clinical efficacy and advanced technological capabilities of its flagship product lines—including POTENZA (Microneedle RF), DENSITY (Monopolar/Bipolar RF), and LinearZ (HIFU)—directly in the heart of the European market. The company also declared its strategic transition to accelerate manufacturer-driven global operations, focusing on maximizing customer satisfaction and physician trust worldwide.
On January 28, Jeisys Medical hosted its premier pre-congress event, 'TEA Paris 2026,' at The Peninsula Paris. The exclusive symposium attracted approximately 100 elite global distributors and Key Opinion Leaders (KOLs) from Europe, the Americas, and Asia. Under the central theme, "POTENZA Unveiled: Shaping the Next Era of RF Microneedling," the event successfully highlighted Jeisys Medical's technological innovation, fostering high-level networking and aligning international partners with the company's long-term global vision.
Following the symposium, Jeisys Medical participated in 'IMCAS Paris 2026' from January 29 to 31 as an official Gold Sponsor. The company operated the 'Experience Jeisys' showcase, featuring six of its premium medical platforms, including POTENZA, DENSITY Noir, and LinearZ. The booth garnered significant attention from international dermatologists and plastic surgeons through a series of clinical lectures delivered by global aesthetic experts, alongside interactive, hands-on training sessions.
"The Paris events served as a critical milestone to accelerate our manufacturer-driven global strategy, with POTENZA leading the expansion to deliver unprecedented value to the aesthetic market," said an official from Jeisys Medical. "Moving forward, Jeisys Medical remains committed to deepening our collaborative partnerships with global practitioners and continuously introducing data-driven, innovative medical platforms to elevate patient outcomes."